As the coronavirus pandemic lengthens and economic recession continues in 2021, how will patients, consumers, and caregivers view the pharma industry? It’s about trust and transparency, we discussed with Medical Marketing & Media‘s editor, Marc Iskowitz.
“Everybody loves pharma?” – Jane’s analysis in MM&M on the pharma industry in the pandemic
By Jane Sarasohn-Kahn on 4 August 2020 in
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global pharmaceutical company.
Thank you Aaron Strout for hosting our conversation on the Reaching Higher Podcast, now live on Apple, Spotify, and YouTube. We covered a lot of ground addressing health care and health citizenship, the growing prospects for our homes as our health hubs, and how our humanity is a key ingredient in health-making for all.
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance. Click onto the Pfizer Value of Vaccines site and you can watch four episodes covering the challenges with adult vaccination, the employer and health plan member's journey to vaccination, reimbursement, and collaborating for proactive prevention.